Todd Harris, Chief Executive Officer at Tyra Biosciences, Inc. (TYRA), sold 2,000 shares at $16.13 ($32K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($32k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |